LEBWOHL, M.; SUGARMAN, J.; PARISER, D.; BAGEL, J.; LIN, T.; ISRAEL, R. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 1, p. S12, 2020. Disponível em: https://www.jofskin.org/index.php/skin/article/view/826. Acesso em: 10 dec. 2022.